Cargando…
Case-control study on PCSK9 R496W (rs374603772) and D374Y (rs137852912) mutations in Turkish patients with primary dyslipidemia
OBJECTIVE: The aim of this study was to investigate the relationships between F216L (rs28942112), R496W (rs374603772), S127R (rs28942111), and D374Y (rs137852912) PCSK9 gain-of-function (GOF) mutations and primary dyslipidemia and serum lipid levels in patients with primary dyslipidemia. METHODS: In...
Autores principales: | Eroğlu, Zuhal, Vardarlı, Aslı Tetik, Düzgün, Zekeriya, Gündüz, Cumhur, Çetintaş, Vildan Bozok, Kayıkçıoğlu, Meral |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280272/ https://www.ncbi.nlm.nih.gov/pubmed/29724976 http://dx.doi.org/10.14744/AnatolJCardiol.2018.86648 |
Ejemplares similares
-
PCSK 9 gain-of-function mutations (R496W and D374Y) and clinical cardiovascular characteristics in a cohort of Turkish patients with familial hypercholesterolemia
por: Kaya, Esra, et al.
Publicado: (2017) -
Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension
por: DÜZGÜN, Zekeriya, et al.
Publicado: (2022) -
Polymorphisms of lipid metabolism enzyme-coding genes in patients with diabetic dyslipidemia
por: Vardarlı, Aslı Tetik, et al.
Publicado: (2017) -
LDLR C1725T Gene Polymorphism Frequency in Type 2 Diabetes Mellitus Patients With Dyslipidemia
por: Eroglu, Zuhal, et al.
Publicado: (2016) -
The effects of PIKfyve inhibitor YM201636 on claudins and malignancy potential of nonsmall cell cancer cells
por: DOĞAN, Eda, et al.
Publicado: (2021)